Kallmann syndrome
Also known as Kallman syndrome, Kallman's syndrome, Olfacto-genital pathological sequence, congenital hypogonadotropic hypogonadism with anosmia+3 more
Kallman syndrome, Kallman's syndrome, Olfacto-genital pathological sequence, congenital hypogonadotropic hypogonadism with anosmia, familial hypogonadism with anosmia, hypogonadism with anosmia, hypogonadotropic hypogonadism with anosmia.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
A genetically heterogeneous disorder caused by hypothalamic GNRH deficiency and OLFACTORY NERVE defects. It is characterized by congenital HYPOGONADOTROPIC HYPOGONADISM and ANOSMIA, possibly with additional midline defects. It can be transmitted as an X-linked (GENETIC DISEASES, X-LINKED), an autosomal dominant, or an autosomal recessive trait.
Kallman syndrome, Kallman's syndrome, Olfacto-genital pathological sequence, congenital hypogonadotropic hypogonadism with anosmia, familial hypogonadism with anosmia, hypogonadism with anosmia, hypogonadotropic hypogonadism with anosmia
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Related entities are derived from literature co-mention (studied together) — associative, not causal.